Review article · 2025 · Open access

Gut microbial metabolites in cancer immunomodulation

Hengshuo Liu, Xingyu Xiong, Weizhen Zhu, Sheng Wang, Wei-Chao Huang, Guo‐Qing Zhu, Hang Xu, Lu Yang

Molecular Cancer, 25(1), 8 · Published 3 December 2025 · DOI 10.1186/s12943-025-02521-5

Open full textCite this paper

In brief

“Gut microbial metabolites in cancer immunomodulation” is a 2025 review article by Hengshuo Liu and 7 co-authors, published in Molecular Cancer. OpenAlex counts 62 citations as of 18 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular Cancer.

Citations
62
Most cited in
2026 (61)
Field-weighted impact
3.94
References
281
Authors
8

Abstract

Gut microbiota-derived metabolites are emerging as systemic "remote immunoregulators" that shape tumor immunity across tissues. Integrating evidence across short-chain fatty acids, tryptophan derivatives, secondary bile acids, polyamines and other metabolites, we advance a metabolite-immune pathway-cancer framework that links receptor-mediated signaling, epigenetic remodeling and metabolic reprogramming to context-dependent, bidirectional immune effects. Importantly, in addition to the g protein-coupled receptor / aryl hydrocarbon receptor pathway, the selected microbial small molecule metabolites are the true T-cell receptor ligands of unconventional T cells, directly shaping the tissue resident immune and tumor microenvironment, supplementing the receptor signaling and epigenetic programs in our framework. We synthesize how these metabolites recalibrate the tumor immune microenvironment-modulating antigen presentation, T-cell effector fitness and exhaustion, regulatory T-cell activity, and myeloid polarization-and why the same metabolite can either potentiate immune surveillance or entrench immunosuppression depending on ligand-receptor pairing, dose and tissue niche. We compare tumor-type specific patterns (e.g., colorectal, liver, lung, breast and prostate cancers) to highlight common circuits and organ-restricted idiosyncrasies. Methodologically, we outline how single-cell and spatial multi-omics, imaging mass spectrometry and functional biosensors now enable co-registration of metabolite exposure with immune-cell states in human tumors, providing an actionable basis for biomarker discovery. Given ongoing debate about signals attributed to intratumoral microbiota in low-biomass tumor tissues, we foreground quantifiable, spatially mappable and pharmacologically tractable metabolite-receptor pathways, using microbe-associated molecular patterns / translocation as comparators to judge when chemical signals should be prioritized as intervention targets. Finally, we evaluate precision intervention avenues-including fecal microbiota transplantation, rational bacterial consortia, engineered microbes and nanoparticle-enabled metabolite delivery-and propose stratification rules that pair metabolite/receptor signatures with fit-for-purpose delivery. Together, mapping tissue-specific metabolite-immune circuits and embedding them in robust biomarker frameworks may convert microbial metabolites from correlative markers into therapeutic targets and tools, improving the efficacy and durability of cancer immunotherapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, H., Xiong, X., Zhu, W., Wang, S., Huang, W.-C., Zhu, G., Xu, H., & Yang, L. (2025). Gut microbial metabolites in cancer immunomodulation. Molecular Cancer, 25(1), 8. https://doi.org/10.1186/s12943-025-02521-5

MLA 9

Liu, Hengshuo, et al. “Gut microbial metabolites in cancer immunomodulation.” Molecular Cancer, vol. 25, no. 1, 2025, p. 8. https://doi.org/10.1186/s12943-025-02521-5.

Chicago

Liu, Hengshuo, Xingyu Xiong, Weizhen Zhu, Sheng Wang, Wei-Chao Huang, Guo‐Qing Zhu, Hang Xu, and Lu Yang. 2025. “Gut microbial metabolites in cancer immunomodulation.” Molecular Cancer 25 (1): 8. https://doi.org/10.1186/s12943-025-02521-5.

Harvard

Liu, H. et al. (2025) ‘Gut microbial metabolites in cancer immunomodulation’, Molecular Cancer, 25(1), p. 8. doi:10.1186/s12943-025-02521-5.

IEEE

H. Liu et al., “Gut microbial metabolites in cancer immunomodulation,” Molecular Cancer, vol. 25, no. 1, p. 8, 2025, doi: 10.1186/s12943-025-02521-5.

BibTeX

@article{liu2025microbial,
  title     = {{Gut microbial metabolites in cancer immunomodulation}},
  author    = {Liu, Hengshuo and Xiong, Xingyu and Zhu, Weizhen and Wang, Sheng and Huang, Wei-Chao and Zhu, Guo‐Qing and Xu, Hang and Yang, Lu},
  journal   = {Molecular Cancer},
  year      = {2025},
  volume    = {25},
  number    = {1},
  pages     = {8},
  doi       = {10.1186/s12943-025-02521-5},
  url       = {https://doi.org/10.1186/s12943-025-02521-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • gut microbiota metabolites
  • tumor immunomodulation
  • short-chain fatty acids
  • tryptophan metabolites
  • secondary bile acids
  • polyamines
  • aryl hydrocarbon receptor
  • G protein-coupled receptors

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Liu, H., Xiong, X., Zhu, W., Wang, S., Huang, W.-C., Zhu, G., Xu, H., & Yang, L. (2025). Gut microbial metabolites in cancer immunomodulation. Molecular Cancer, 25(1), 8. https://doi.org/10.1186/s12943-025-02521-5

How many times has this paper been cited?

62 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular Cancer: sign in and open the full text from this page.

Who wrote this paper?

Hengshuo Liu, Xingyu Xiong, Weizhen Zhu, Sheng Wang, Wei-Chao Huang, Guo‐Qing Zhu, Hang Xu, Lu Yang.

What is the DOI of this paper?

10.1186/s12943-025-02521-5, permanently at https://doi.org/10.1186/s12943-025-02521-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.